Notably, deletion of SMURF1 in ovarian cancer cells increased DAB2IP levels and reduced proliferation, invasion and EMT; depletion of DAB2IP restored proliferation and EMT in SMURF1-knockout cells, suggesting that SMURF1 is required to maintain low levels of DAB2IP in ovarian cancer [80]. This evidence concerns the gene DAB2IP and ovarian cancer.